Asuka Nakata

Pós-doutorado

Idiomas

Áreas de atuação

Produções bibliográficas

• MURAYAMA, T. ; NAKAOKU, T. ; ENARI, M. ; NISHIMURA, T. ; TOMINAGA, K. ; NAKATA, A. ; TOJO, A. ; SUGANO, S. ; KOHNO, T. ; GOTOH, N. . Oncogenic Fusion Gene CD74-NRG1 Confers Cancer Stem Cell-like Properties in Lung Cancer through a IGF2 Autocrine/Paracrine Circuit. CANCER RESEARCH , v. 76, p. 974-983, 2016.

• KONNO, MASAMITSU ; ISHII, HIDESHI ; KOSEKI, JUN ; TANUMA, NOBUHIRO ; NISHIDA, NAOHIRO ; KAWAMOTO, KOICHI ; NISHIMURA, TATSUNORI ; NAKATA, ASUKA ; MATSUI, HIDETOSHI ; NOGUCHI, KOZOU ; OZAKI, MIYUKI ; NOGUCHI, YUKO ; SHIMA, HIROSHI ; GOTOH, NORIKO ; NAGANO, HIROAKI ; DOKI, YUICHIRO ; MORI, MASAKI . Pyruvate kinase M2, but not M1, allele maintains immature metabolic states of murine embryonic stem cells. Regenerative Therapy , v. 1, p. 63-71, 2015.

• NADAL, ERNEST ; TRUINI, ANNA ; NAKATA, ASUKA ; LIN, JULES ; REDDY, RISHINDRA M. ; CHANG, ANDREW C. ; RAMNATH, NITHYA ; GOTOH, NORIKO ; BEER, DAVID G. ; CHEN, GUOAN . A Novel Serum 4-microRNA Signature for Lung Cancer Detection. Scientific Reports , v. 5, p. 12464, 2015.

• NAKATA, ASUKA ; YOSHIDA, RYO ; YAMAGUCHI, RUI ; YAMAUCHI, MAI ; TAMADA, YOSHINORI ; FUJITA, ANDRE ; SHIMAMURA, TEPPEI ; IMOTO, SEIYA ; HIGUCHI, TOMOYUKI ; NOMURA, MASAHARU ; KIMURA, TATSUO ; NOKIHARA, HIROSHI ; HIGASHIYAMA, MASAHIKO ; KONDOH, KAZUYA ; NISHIHARA, HIROSHI ; TOJO, ARINOBU ; YANO, SEIJI ; MIYANO, SATORU ; GOTOH, NORIKO . Elevated β-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs. Scientific Reports , v. 5, p. 13076, 2015.

• NAKATA, ASUKA ; GOTOH, NORIKO . Recent understanding of the molecular mechanisms for the efficacy and resistance of EGF receptor-specific tyrosine kinase inhibitors in non-small cell lung cancer. EXPERT OPINION ON THERAPEUTIC TARGETS , v. 16, p. 771-781, 2012.

• YAMAUCHI, MAI ; YAMAGUCHI, RUI ; NAKATA, ASUKA ; KOHNO, TAKASHI ; NAGASAKI, MASAO ; SHIMAMURA, TEPPEI ; IMOTO, SEIYA ; SAITO, AYUMU ; UENO, KAZUKO ; HATANAKA, YOUSUKE ; YOSHIDA, RYO ; HIGUCHI, TOMOYUKI ; NOMURA, MASAHARU ; BEER, DAVID G. ; YOKOTA, JUN ; MIYANO, SATORU ; GOTOH, NORIKO . Epidermal Growth Factor Receptor Tyrosine Kinase Defines Critical Prognostic Genes of Stage I Lung Adenocarcinoma. PLoS One , v. 7, p. e43923, 2012.

• NAKATA, ASUKA ; URANO, DAISUKE ; FUJII-KURIYAMA, YOSHIAKI ; MIZUNO, NORIKAZU ; TAGO, KENJI ; ITOH, HIROSHI . G-protein signalling negatively regulates the stability of aryl hydrocarbon receptor. EMBO REPORTS , v. 10, p. 622-628, 2009.

• URANO, DAISUKE ; NAKATA, ASUKA ; MIZUNO, NORIKAZU ; TAGO, KENJI ; ITOH, HIROSHI . Domain-domain interaction of P-Rex1 is essential for the activation and inhibition by G protein βγ subunits and PKA. CELLULAR SIGNALLING , v. 20, p. 1545-1554, 2008.

• DE SIQUEIRA SANTOS, S. ; TAKAHASHI, D. Y. ; NAKATA, A. ; FUJITA, A. . A comparative study of statistical methods used to identify dependencies between gene expression signals. BRIEFINGS IN BIOINFORMATICS , v. 15, p. 906-918, rint.

• NISHIMURA, T. ; NAKATA, A. ; XIAOXI, C. ; NISHI, K. ; MEGURO-HORIKE, M. ; SASAKI, S. ; KITA, K. ; HORIKE, S. ; SAITOH, K. ; KATO, K. ; KAORI, I. ; MURAYAMA, T. ; KOHNO, S. ; TAKAHASHI, C. ; MUKAIDA, N. ; YANO, S. ; SOGA, T. ; TOJO, A. ; GOTOH, N. . Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2. Oncogene , 2018.

Projetos de pesquisa

• 2015 - 2017

  Evaluation of KLK3 as a biomarker for breast cancer, Descrição: Financiado pelo Japan Society for Promotion of Science - Grant-in-Aid for Young Scientists. Valor recebido: ~R$152.000,00.. , Situação: Concluído; Natureza: Pesquisa.

• 2014 - 2016

  Development of diagnostic system of mutations in breast cancer by using primary sphered cells derived from patients, Descrição: Financiado pelo Japan Society for the Promotion of Science - Grant-in-Aid for challenging Exploratory Research. Valor recebido: ~R$142.500,00.. , Situação: Concluído; Natureza: Pesquisa.

• 2013 - 2015

  Novel molecular mechanisms of acquired resistance to gefitinib in lung adenocarcinoma., Descrição: Financiado pelo Japan Society for Promotion of Science - Grant-in-Aid for Young Scientists. Valor recebido: ~R$133.000,00. , Situação: Concluído; Natureza: Pesquisa.

• 2013 - 2015

  Start-up grant, Descrição: Financiado pelo Japan Science and Technology Agency. Valor recebido: ~R$373.000,00.. , Situação: Concluído; Natureza: Pesquisa.

Prêmios